Feature Channels:

OBGYN

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Pregnancy, Body Mass Index, Weight Gain, Adolescence, Mother and child

New Study: Pre-Pregnancy BMI Directly Linked to Excess Pregnancy Weight Gain

It’s well known that excessive weight gain during pregnancy can have a lasting negative impact on the health of a mother and her baby. A new University of Michigan-led study finds that for young mothers (women who gave birth between the ages of 15 and 24), pre-pregnancy body mass index, or BMI, and ethnicity might signal a likelihood for obesity later in life.

Medicine

Channels:

Prostate Cancer

New Insights Into Side Effects Can Help Prostate Cancer Patients Choose Treatments

RonChenHorizontal.jpg

A new study led by UNC Lineberger Comprehensive Cancer Center researchers identifies distinct patterns of side effects for prostate cancer treatments that patients could use to guide their choices.

Medicine

Channels:

Prostate Cancer, Vanderbilt University Medical Center, Daniel Barocas, David Penson, Prostate Cancer Surgery, Radiation, Active Surveillance

Active Surveillance Preserves Quality of Life for Prostate Cancer Patients

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).

Medicine

Channels:

Breast Cancer, Disparities in Breast Cancer, Yale Cancer Center

Racial Disparities in Genetic Testing of Women with Breast Cancer

CaryGross.jpg

Medicine

Channels:

Immunotherapy, Prostate Cancer, MD Anderson Cancer Center

Combination Immunotherapy Effective for Advanced Prostate Cancer

Researchers at The University of Texas MD Anderson Cancer Center developed a novel chimeric mouse model to test the combination therapy using immune checkpoint blockades with therapies targeting myeloid-derived suppressor cells (MDSCs).

Medicine

Channels:

Researchers Discover Key to Drug Resistance in Common Breast Cancer Treatment

nettles_kendall.jpg

Scientists from the Florida campus of The Scripps Research Institute (TSRI), the University of California (UC), San Diego and the University of Illinois have found that two immune system molecules may be key to the development of drug resistance in estrogen-driven breast cancers.

Medicine

Channels:

Focused Ultrasound, Breast, breast fibroadenoma, Breast Tumor

Pivotal Trial Begins for Breast Fibroadenoma Using Focused Ultrasound

FUSBreninRochman_23.JPG

Patients with benign breast tumors may be eligible for a new focused ultrasound–based investigational treatment as part of a pivotal, multi-center clinical study. The trial began last month at the University of Virginia (UVA) Medical Center.

Medicine

Channels:

NCCN, Yale Cancer Center, Racial Disparities, Breast Cancer

Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer

jnccn.jpg

The study, “Racial and Ethnic Disparities in Oncotype Dx™ Test Receipt in a State-Wide Population-Based Study,” led by Cary P. Gross, MD, Yale University School of Medicine and a member of Yale Cancer Center, is published in the March issue of JNCCN – Journal of the National Comprehensive Cancer Network.

Medicine

Channels:

Tulane University School of Medicine, Estrogen, Menopausal Hormone Therapy, Hormone Replacement Therapy, Estrogen Receptor

Tulane Researcher Awarded $1.9 Million to Improve Menopausal Hormone Therapy

031517_sarah-lindsey800_6684_pbc.jpeg

New research at the Tulane University School of Medicine is looking at an estrogen receptor that could be a site for targeted hormone replacement therapy in post-menopausal women.

Medicine

Channels:

Prostate, Prostate Cancer, clinical trial, Prostate Cancer Treatment, Radiation, Radiation Therapy, Radiation Treatment, men and cancer, princess margaret cancer centre, University Health Network

Prostate Cancer Clinical Trial Shows Treating with Precision Radiotherapy Reduces Course of Treatment by 50%

Dr.CharlesCatton.jpg

An Ontario-led international clinical trial with 1,206 men with localized prostate cancer shows that compressing radiation treatments into four weeks from eight delivers similar outcomes.







Chat now!